We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+12.3%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$51B
AUM Growth
+$15.4B
(+43%)
Cap. Flow
+$11.4B
Cap. Flow
% of AUM
22.45%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
2,383
New
382
Increased
1,739
Reduced
215
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$973M |
| 2 |
Microsoft
MSFT
|
+$944M |
| 3 |
Meta Platforms (Facebook)
META
|
+$686M |
| 4 |
Amazon
AMZN
|
+$561M |
| 5 |
NVIDIA
NVDA
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leggett & Platt
LEG
|
+$127M |
| 2 |
PBCT
People's United Financial Inc
PBCT
|
+$25.8M |
| 3 |
Albemarle
ALB
|
+$25.2M |
| 4 |
CDW
CDW
|
+$25.2M |
| 5 |
Factset
FDS
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Communication Services | 11.47% |
| 4 | Healthcare | 9.06% |
| 5 | Consumer Staples | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
2126
DELISTED
Allakos
ALLK
| $150K | ﹤0.01% |
15,397
-616
| -4% | -$50.5K |
|
|
FSP
2127
Franklin Street Properties
FSP
$44.8M
| $150K | ﹤0.01% |
25,175
+9,459
| +60% | +$52.9K |
|
2128
The Honest Company
HNST
$417M
| $150K | ﹤0.01% |
+18,584
| New | +$163K |
|
|
GTHX
2129
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $149K | ﹤0.01% |
14,647
+577
| +4% | +$7.35K |
|
2130
International Seaways
INSW
$4.57B
| $148K | ﹤0.01% |
+10,034
| New | +$166K |
|
|
OMIC
2131
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $148K | ﹤0.01% |
+426
| New | +$165K |
|
2132
Costamare
CMRE
$1.9B
| $147K | ﹤0.01% |
+11,537
| New | +$151K |
|
2133
MiMedx Group
MDXG
$626M
| $147K | ﹤0.01% |
24,265
+10,031
| +70% | +$69.7K |
|
2134
Expro Ltd
XPRO
$1.79B
| $147K | ﹤0.01% |
10,160
+6,612
| +186% | +$108K |
|
|
LENZ
2135
LENZ Therapeutics
LENZ
$172M
| $147K | ﹤0.01% |
+1,676
| New | +$139K |
|
2136
Precision BioSciences
DTIL
$188M
| $144K | ﹤0.01% |
653
+17
| +3% | +$4.75K |
|
|
CPRX
2137
DELISTED
Catalyst Pharmaceutical
CPRX
| $143K | ﹤0.01% |
21,216
+8,774
| +71% | +$57.7K |
|
2138
Lexicon Pharmaceuticals
LXRX
$1.02B
| $143K | ﹤0.01% |
+36,257
| New | +$176K |
|
2139
Arbutus Biopharma
ABUS
$865M
| $142K | ﹤0.01% |
36,599
+5,122
| +16% | +$19.9K |
|
2140
Akebia Therapeutics
AKBA
$327M
| $142K | ﹤0.01% |
62,741
+3,107
| +5% | +$8.47K |
|
2141
Omeros
OMER
$709M
| $141K | ﹤0.01% |
21,984
+907
| +4% | +$6.58K |
|
2142
Titan International
TWI
$516M
| $140K | ﹤0.01% |
+12,761
| New | +$100K |
|
2143
Altimmune
ALT
$539M
| $139K | ﹤0.01% |
15,277
+1,714
| +13% | +$18.2K |
|
2144
Annexon
ANNX
$855M
| $139K | ﹤0.01% |
12,217
+34
| +0.3% | +$549 |
|
2145
Pliant Therapeutics
PLRX
$67.5M
| $139K | ﹤0.01% |
10,335
-424
| -4% | -$6.74K |
|
|
CNSL
2146
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $139K | ﹤0.01% |
18,584
+6,970
| +60% | +$57.4K |
|
|
IMA
2147
ImageneBio Inc
IMA
$63.1M
| $138K | ﹤0.01% |
+926
| New | +$150K |
|
|
YELL
2148
DELISTED
Yellow Corporation Common Stock
YELL
| $138K | ﹤0.01% |
+10,985
| New | +$120K |
|
2149
SunCoke Energy
SXC
$757M
| $137K | ﹤0.01% |
20,768
+7,969
| +62% | +$52.8K |
|
2150
Geron
GERN
$911M
| $136K | ﹤0.01% |
111,916
+4,785
| +4% | +$6.86K |
|
Similar funds
ProShare Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, ProShare Advisors held 2,383 positions worth $51B, up 43% from $35.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
ProShare Advisors deployed $11.4B of net new capital in Q4 2021, opening 382 new positions and adding to 1,739 existing holdings. Its largest new stake was Lucid Motors: 272,628 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Leggett & Platt, an estimated $127M trimmed.
- ProShare Advisors's largest Q4 2021 buy was Lucid Motors: 272,628 shares worth $104M.
- ProShare Advisors added most to Apple in Q4 2021, an estimated $973M increase.
- ProShare Advisors's biggest Q4 2021 reduction was Leggett & Platt, cutting an estimated $127M.
- ProShare Advisors fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $20.9M.
- ProShare Advisors's ten largest holdings make up 33% of its $51B portfolio in Q4 2021.
- ProShare Advisors opened 382 new positions and closed 45 in Q4 2021.
- ProShare Advisors's portfolio value rose 43% quarter-over-quarter to $51B.
Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.